Franklin Resources Inc Ultragenyx Pharmaceutical Inc. Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 218,903 shares of RARE stock, worth $9.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218,903

Previous 293,894 25.52%

Holding current value

$9.8 Million

Previous $12.1 Million 0.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$40.21 - $59.36 $3.02 Million - $4.45 Million	-74,991 Reduced 25.52%	218,903 $12.2 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $2.92 Million - $4.02 Million	77,978 Added 36.11%	293,894 $12.1 Million
Q1 2024 May 13, 2024	BUY	$43.02 - $53.69 $50,677 - $63,246	1,178 Added 0.55%	215,916 $10.1 Million
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $797,819 - $1.24 Million	25,144 Added 13.26%	214,738 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $348,361 - $465,480	9,976 Added 5.55%	189,594 $6.76 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $4,706 - $6,570	126 Added 0.07%	179,618 $8.29 Million
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $59,184 - $77,936	-1,600 Reduced 0.88%	179,492 $7.2 Million
Q4 2022 Feb 10, 2023	BUY	$33.72 - $46.33 $92,021 - $126,434	2,729 Added 1.53%	181,092 $8.39 Million
Q3 2022 Nov 14, 2022	SELL	$39.96 - $66.14 $33,326 - $55,160	-834 Reduced 0.47%	178,363 $7.39 Million
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $870 - $1,181	-14 Reduced 0.01%	179,197 $13 Million
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $1.71 Million - $2.04 Million	-23,250 Reduced 11.48%	179,211 $15.1 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $5,921 - $7,782	76 Added 0.04%	202,461 $18.3 Million
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $3,871 - $4,859	-42 Reduced 0.02%	202,385 $19.3 Million
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $5.52 Million - $8.66 Million	-51,651 Reduced 20.33%	202,427 $23 Million
Q4 2020 Feb 10, 2021	SELL	$84.4 - $177.39 $10.9 Million - $22.8 Million	-128,749 Reduced 33.63%	254,078 $35.2 Million
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $25,834 - $31,860	354 Added 0.09%	382,827 $31.5 Million
Q1 2020 May 13, 2020	BUY	$33.8 - $62.9 $399,617 - $743,666	11,823 Added 3.19%	382,473 $17 Million
Q4 2019 Feb 12, 2020	BUY	$36.08 - $45.83 $8.13 Million - $10.3 Million	225,200 Added 154.83%	370,650 $15.8 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $6.18 Million - $9.18 Million	145,450 New	145,450 $6.22 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Ultragenyx Pharmaceutical Inc. Transaction History